No Data
No Data
Autobio Diagnostics (603658.SH): has repurchased 1.60% of the shares.
Grain Note 2 December२२.Autobio Diagnostics (603658.SH) announced that as of November 30, 2024, the company has repurchased a total of 9,308,752 shares through centralized competitive trading, accounting for 1.60% of the company's total share capital. The highest price traded was 59.99 yuan/share, the lowest price was 37.91 yuan/share, and the total amount paid was 433,868,879.17 yuan (excluding transaction costs).
Autobio Diagnostics: Molecular sector is growing rapidly, subsidiary disputes may be resolved soon | Earnings Conference
① The secretary of the board of directors of autobio diagnostics stated at the earnings conference that the significant increase in R&D expenses led to a decline in Q3 net income attributable to the parent company; ② The chairman of autobio diagnostics, Miao Yongjun, informed investors that the molecular sector is expected to maintain high-speed growth, while the microbiology sector will achieve steady growth of 15%-20% each year.
Is Autobio Diagnostics Co., Ltd.'s (SHSE:603658) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Sinolink Securities: Pharmaceutical prosperity in the third quarter hovers at the bottom, focusing on the improvement prospects for the next 25 years.
In the third quarter, due to internal adjustments in the healthcare sector, changes in the consumer environment, and some medical insurance cost control policies still being implemented, the business climate continued to bottom out in the Q3 report, with a slower rebound than expected.
autobio diagnostics (603658.SH): has cumulatively repurchased 1.58% of shares
On November 1, GeLonghui reported that autobio diagnostics (603658.SH) announced that as of October 31, 2024, the company has repurchased a total of 9,174,352 shares through centralized auction trading, accounting for 1.58% of the total share capital of the company. The highest price transacted was 59.99 yuan/share, the lowest price was 37.91 yuan/share, and the total amount paid was 427,735,574.17 yuan (excluding transaction costs).
Autobio Diagnostics Co., Ltd. Just Missed EPS By 15%: Here's What Analysts Think Will Happen Next
No Data